For instance, toxic mRNA gain-of-function takes place in FXTAS, as revealed by the elevated expression of FMR1 mRNA46, along with the diminished expression of FMRP11. The gene discussed is FMR1; the disease is fragile X-associated tremor/ataxia syndrome.